Dissociation from epithelial sheets and invasion through the surrounding stroma are critical early events during epithelial cancer metastasis. Here we find that a lymphocyte lineagerestricted transcription factor, Spi-B, is frequently expressed in human lung cancer tissues. The DOI: 10.1158/0008-5472.CAN-17-0020 3 Claudin-2 (CLDN2) and repressing its transcription. These data suggest that Spi-B participates in mesenchymal invasion, linking epithelial cancer metastasis with a lymphatic transcriptional program.
Author Manuscript Published OnlineFirst on July 28, 2017; DOI: 10.1158/0008-5472. lymphoma (ABC DLBCL). Its expression is required for the survival of ABC DLBCL lines and contributes to apoptosis resistance via the PI3K-AKT pathway (10) (11) (12) . In addition, gene expression profiling analysis has detected Spi-B in some malignant solid tumors including gastric cancer (13) and colorectal cancer (14) . Immunohistochemical staining also detected Spi-B in hepatocellular carcinoma (15, 16) , suggesting that Spi-B may be aberrantly expressed in some solid tumors. However, the functional consequence of Spi-B expression in carcinomas is completely unknown.
Here, we report that Spi-B is expressed in invasive cancer cells in human primary lung cancer tissues. Expression of Spi-B in lung cancer cells downregulates Claudin-2 and thereby disrupting intercellular junctions and enhancing invasive behavior. These data identify an epigenetic process linking hematopoietic lineage gene control with local invasion in metastatic carcinoma cells, and suggest that Spi-B may be an effective biomarker for both prognosis and treatment of lung cancer. PowerPlex 1.2 analysis system (Genewiz Inc.). Data were analyzed using GeneMapper4.0 software and then compared with the ATCC databases for reference matching.
Materials and Methods

Cells
In vivo metastasis assay
LLC1 expressing empty vector or SPIB were selected by cell sorting for GFP expression (FACS Vantage, BD). 10 5 cells of each group in 100 μl saline were subcutaneously injected into 8-weekold C57BL/6 mice. Tumors in situ were excised 2 weeks after the inoculation of cells. 2 weeks after resection, the mice were sacrificed and metastatic nodules formation in the lungs was analyzed.
10
6 cells of LLC1 cells in 100 μl saline were injected into the tail vein of 8-week-old C57BL/6 mice. At one month following injection, the mice were sacrificed and metastatic nodules formation in the lungs was analyzed.
LLC1-luc cell line was established using a lentivirus encoding the luciferase gene, and stable clones were isolated by puromycin selection. GFP sorted LLC1-luc cells expressing empty vector, SPIB, or CLDN2 and SPIB were subcutaneously injected as above. The whole lungs were immediately grinded in liquid nitrogen and total protein was used to detect tumor metastasis by assaying luciferase activity. All animal procedures were approved by Animal Care and Use
Committee at Tianjin Medical University and conform to the legal mandates and national guidelines for the care and maintenance of laboratory animals. 
Immunohistochemical Analysis
Invasion Assay
Assays were performed in trans-well inserts with 8 μm pores (BD Biosciences) coated with 20% growth-factor-reduced Matrigel. Tumor cells in serum-free medium (2×10 5 cells per well) were seeded into the upper chamber and complete media was placed in the lower chambers as a chemo-attractant. The chambers were incubated for 20 h at 37℃ with 5% CO 2 . Experiments were performed in triplicate. Migrated cells on the undersides of filter membrane were fixed in 4%
formalin and stained with crystal violet. The migrated cells were counted using light microscopy.
Soft Agar
Cells (1×10   4   ) were resuspended in DMEM containing 10% FBS with 0.35% agarose and layered on top of 0.6% agarose in DMEM on 6-well plates. Cells were cultured for 21 days at 37℃ with 5% CO 2 . Experiments were performed in triplicate. Colonies were stained, analyzed morphologically and counted using light microscopy.
3D Matrigel Culture
These assays were optimized from previous publication (17) . Tumor cells were detached with 0.25% trypsin-EDTA, centrifuged (1,000 rpm for 3 min), resuspended, and counted. Single cells (2×10 3 per well performed in triplicate) were mixed into 0.4 ml of RPMI1640 medium supplemented with 2% FBS and 5% chilled growth factor reduced Matrigel (BD Biosciences), and cultured in suspension in 24-well ultra-low attachment plate (Corning) at 37℃ for 14 days.
Experiments were performed in triplicate. The organoids were categorized based on their 
Chromosome conformation capture
Chromosome conformation capture (3C) was performed as described previously (19) . 10 6 cells were cross-linked, lysed, and nuclei were digested with Dpn II. After ligation and subsequent DNA purification, the cross-linking frequencies between the anchor and test fragments were estimated by PCR reactions relative to standards. Three PCR products together containing from the CLDN2 gene promoter to all upstream regulatory elements were amplified, mixed at equal molar ratios, digested with Dpn II, and ligated at high concentrations to generate all possible ligation products. The cross-linking and ligation efficiencies between different samples were normalized by setting the highest cross-linking frequency to 1.0. Primers used in this study are provided in the Table S1 .
Chromatin Immunoprecipitation
ChIP was performed as described previously (19) . Antibody against H3K4me3 was from Millipore; antibody against flag M2-agarose was from Sigma. Results were quantified by realtime PCR with SYBR Green dye using the ABI Prism 7900 system (Applied Biosystems). All PCR signals from immunoprecipitation samples were referenced to their respective inputs to normalize for differences in primer efficiencies. Primers used in this study are listed in Table S1 .
Luciferase Assay
DNA fragments of CLDN2 promoter and cis-regulatory elements upstream were amplified from HUVEC DNA using primers listed in Table S1 . CLDN2 promoter was inserted into the XhoI and the Hind III site of the polylinker region pGL3-basic. Cis-regulatory elements were inserted into the Kpn I and Xho I site. Cell lines were transiently cotransfected either in triplicate or in duplicate with pRL-CMV Renilla luciferase reporter, which was used for normalization Reactions were analyzed by electrophoresis on a 6.0% non-denaturing polyacrylamide gel at 100 V for 1 h. After transfer, the membrane was immediately cross-linked for 1 min on a UV-light crosslinker instrument equipped with 254 nm bulbs. A chemiluminescent detection method utilizing a luminol/enhancer solution and a stable peroxide solution (Pierce, USA) was used as described by the manufacture and the membrane was exposed to X-ray films to visualize the bands.
Transmission electron microscopy
Cells in three-dimensional basement membrane gels were fixed in a fixative solution containing 2.5% glutaraldehyde. After being washed several times in PBS, the cells were then postfixed with 2% osmium tetroxide for 1h at room temperature in darkness, dehydrated in ascending 
Expression Profiling
The expression and functional profiles of genes were compared between A549 cells expressing empty vector and SPIB using Agilent SurePrint G3 Human Gene Expression 8x60K v2
Microarray (Agilent Technologies). Analysis of functional profiling of Spi-B-regulated genes was performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID) based on the biological pathways from KEGG (Kyoto Encyclopedia of genes and genomes) database.
Accession Numbers
The Gene Expression Omnibus accession number for A549 cell expression profile data is GSE90645.
Statistical Analysis
Results were reported as mean ± SD unless otherwise noted. SPSS 18.0 was used for statistical analysis. Correlation of the expression levels between Spi-B and survival rates were determined with Kaplan-Meier analysis using Mantel-Cox log-rank testing (GraphPad Prism). Comparison of expression levels between Spi-B and Claudin-2 was determined by using the Pearson's correlation test and the Spearman's rank correlation test. A p-value of less than 0.05 was considered statistically significant for all tests. Figure 1D ). Consistently, a highly significant negative correlation was found between Spi-B expression level and overall survival time in 9 SCLC subjects with available survival data ( Figure 1E 
Spi-B expression promotes lung metastasis in vivo
To test the functional consequences of Spi-B expression in lung cancers in vivo, lentiviral constructs were introduced into mouse Lewis lung carcinoma (LLC1) cells, which lack detectable endogenous Spi-B expression, and the metastatic capability was assessed. 
Spi-B disrupts intercellular junctions and increases invasive capacity in vitro
We 
tight, gap and adherens junctions. Tight junctions are associated with cell polarity and permeability (20) . Given that overexpression of Spi-B in epithelial cancer cells resulted in the disruption of cell-cell adhesion and the loss of polarity, we focused on the tight junction genes that were downregulated by Spi-B expression. Claudin-2, a key component within tight junctions and whose downregulation was associated with breast cancer metastasis (21-23), was primarily expressed in bronchial epithelium in lung tumor-adjacent tissue ( Figure S3A ) and detected in some epithelial cells of alveoli in lung tumor-adjacent tissue ( Figure S3B ). Downregulation of Claudin-2 by Spi-B was confirmed by immunoblot at the protein level ( Figure 5A ).
To define the correlation between Spi-B and Claudin-2 in individual primary lung cancer tissues, we used IHC to study the expression levels of Spi-B and Claudin-2 in serial sections of NSCLC samples. The representative pictures are shown in Figure 5B . Claudin-2 was expressed in cancer cells that located in the central part of the lung cancer mass. These cancer cells did not express Spi-B. The invasive cancer cells at the tumor-stromal border expressed significant levels of Spi-B but lacked Claudin-2. When intratumoral staining was quantified, a highly significant negative correlation was found between Spi-B and Claudin-2 expression ( Figure 5C ). Therefore, endogenous Spi-B represses Claudin-2 in human lung cancer tissues.
Spi-B promotes metastasis by repressing Claudin-2
To assess whether Spi-B promotes cancer metastasis through Claudin-2 repression, we first tested the cellular effect of Claudin-2 depletion. The efficiency of Claudin-2 knock-down is shown in Figure 6A . Claudin-2 depletion in A549 cells exhibited similar cellular effects as Spi-B overexpression, including decreased cell-cell adhesion in soft agar, the loss of polarity in 3D Matrigel, and enhanced invasion through Matrigel ( Figure 6B, C and D) .
We next re-expressed Claudin-2 in Spi-B-overexpressing A549 cells ( Figure 6E Figure 6H ). However, re-expression of other Spi-B downregulated tight junction proteins, Claudin-14 and Crumbs 3, was not able to restore these changes in cellular behavior caused by Spi-B overexpression ( Figure S4A, S4B and S4C) . Therefore, the changes in cellular behavior caused by enforced Spi-B expression are primarily due to repression of Claudin-2.
To determine whether Spi-B promotes metastasis in vivo through Claudin-2 repression, we reexpressed Claudin-2 in Spi-B-expressing luciferase-labeled LLC1 cells and subcutaneously injected the cells into C57BL/6 mice as described above. Two weeks after removal of the primary tumors, the whole lung tissues were collected for protein extraction and to perform luciferase assays to quantify metastases. Re-expression of Claudin-2 reduced the numbers of both visible lung metastatic nodules and the metastatic luciferase-expressing LLC1 cells to baseline levels ( Figure 6I and J) . Therefore, we identified Claudin-2, a tight junction protein, as the main target of Spi-B in promoting metastasis of lung cancer cells. These results offer an explanation for the association of Spi-B with lymphatic metastasis and overall short survival in human lung cancer patients. 
Spi-B establishes a long-range silencer-promoter interaction and represses CLDN2 transcription
We next explored the mechanism by which Spi-B silences Claudin-2 expression. Claudin-2 is transcribed in A549 cells but not in H1155, H526, H69 and H82 cells ( Figure 7A ). This expression pattern for Claudin-2 is opposite from that which we found for Spi-B. CLDN2 Figure 7C ). We termed these three Spi-B occupied cis-regulatory elements as S1 (-26,001 to -24,893), S2 (-21,765 to -21,450) and S3 (-7,479 to -7,201), which are 25kb, 21kb and 7.5kb upstream of the active promoter, respectively.
Long range communication requires physical interaction (24, 25) . Assuming that S1, S2 or S3 controls CLDN2 gene transcription, physical interactions between these three cis-regulatory elements with the promoter are expected in active or silenced CLDN2. We therefore performed a chromosome conformation capture (3C) assay to explore the chromatin configuration of the CLDN2 gene in A549 and H526 cells, focusing on DNA fragments carrying the S1, S2, S3 and the P1. Briefly, cross-linked chromatin was digested with Dpn II, diluted, re-ligated, and long range association frequencies were assessed with PCR. Indeed, physical interactions between the S3 and the P1 were detected in the active CLDN2 gene in A549 cells when using P1 as an anchor fragment ( Figure 7D ). In addition to the S3-P1 interaction, the S1-P1 interaction was also detected in the silenced CLDN2 gene in H526 cells ( Figure 7D ). The S2, however, did not interact with the promoter either in A549 or H526 cells ( Figure 7D) . Consistently, the H526-specific S1-P1 interaction was also detected when using the S1 as the anchor ( Figure 7E ). These results suggest that the physical interaction between the Spi-B-occupied cis-regulatory element S1 and the promoter may be associated with CLDN2 gene silencing. Then, we overexpressed Spi-B in A549 cells and evaluated the effect of Spi-B on chromatin configurations of CLDN2.
Expectedly, transient expression of Spi-B caused juxtaposition of the S1 to the P1 but had no effect on the interaction between the S3 and the P1 ( Figure 7F ). Thus, aberrant activation of Spi-B in epithelial cancer cells establishes a physical interaction between a cis-regulatory element, S1, with the active promoter of CLDN2.
To investigate the functional consequence of juxtaposition of S1 to the P1 on CLDN2 transcription, we performed luciferase reporter gene assays, a commonly used method for promoter and cis-regulatory element (enhancer or silencer) characterization (26, 27) . We cloned the S1 or the S3 upstream of the P1 flanking the luciferase gene and transfected the constructs into HEK293 cells that normally express Spi-B ( Figure 7G ). While the S3 has no effect on the promoter activity, ectopic placement of the S1 upstream of the P1 completely reduced the promoter activity to the baseline level ( Figure 7H ), indicating that the S1 functions as a silencer of the P1. Two Spi-B-binding consensuses were identified within the S1. EMSA with super shift assay showed direct binding of Spi-B to these two sequences in vitro ( Figure 7I ). Cotransfection of SPIB shRNA or mutation of two Spi-B binding sites within the S1 partially restored promoter activity ( Figure 7J ), suggesting that in addition to establishing a silencer-promoter interaction Spi-B binding to the silencer represses promoter activity.
These data support a model whereby CLDN2 transcription requires decolocalization of an upstream silencer, S1, with the promoter. Spi-B associates with multiple upstream sites including those within the S1, establishing silencer-promoter interactions, and blocking CLDN2 transcription ( Figure 7K ).
Discussion:
For many years, the hypothesis that pathologic processes can be achieved by co-opting a series of physiological processes has been discussed. In the present study, we identified Spi-B, a lymphocyte restricted transcription factor, as a master modulator of invasion of lung cancer cells. CAN-17-0020 of the invasion process require protease-mediated matrix remodeling. For example, protease is required for carcinoma cells to breach the basement membrane that confine the tumor to a local position, to liberate growth factor molecules that are tethered to the basement membrane or stroma, and to invade the stroma. Epithelial cells are unable to produce proteases. Carcinoma cells that retain epithelial markers follow behind stromal fibroblasts that remodel the extracellular matrix to invade (42) . Mesenchymal cells are capable of matrix remodeling (42) , which is consistent with our result that Spi-B is expressed in cancer cells with mesenchymal attributes and upregulates MMP9. Knockdown of MMP9 or overexpression of its inhibitor tissue inhibitor of metalloproteinases 1 (TIMP1) abrogated Spi-B-induced invasion through matrigel in vitro ( Figure S5A and B) . In addition to degrade matrix, MMP9 is involved in TGF- activation (43) , angiogenesis by increasing VEGF bioavailability (44) and is critical for both the invasion of the primary tumor and the formation of the metastatic niche (42, (45) (46) (47) .
Invasion is a fundamental step in tumor progression and a driving force for metastasis. Solid tumors invade the adjacent tissue by single cancer cells or a cluster of connected tumor cells (47, 48) . Two models have been proposed for individual cancer cell invasion: mesenchymal invasion or amoeboid invasion. Mesenchymal invasion is characterized by an elongated morphology that requires extracellular proteolysis localized at cellular protrusions, whereas amoeboid invasion is characterized by a rounded morphology and proteolysis independent (49).
These two invasion modes are both important for carcinoma metastasis and interconvert into each other to adapt to the altered environment (50) . Our results lead us to suggest that Spi-B participates in the mesenchymal invasion of lung cancers. The significant association of Spi-B expression in human lung cancers with invasive behavior substantiates its clinical significance in both prognosis and therapy. 
